European biotech revenues fall back
May 20, 2004Revenues from the European biotech sector have fallen back for the first time in 2003, as many companies across the …
Faslodex launched in UK
May 19, 2004AstraZeneca, Faslodex
The latest addition to AstraZeneca’s oncology franchise, breast cancer drug Faslodex has been launched in the UK.Licensed for the treatment …
Obesity drug collaboration for BMS and Solvay
May 19, 2004Bristol-Myers Squibb and Solvay are to collaborate on the development and marketing of a novel phase I compound for the …
NICE strikes deal with industry on data confidentiality
May 19, 2004The industry and NICE have reached agreement on how the cost and clinical effectiveness body can meet demands for transparency …
TNF-blockers continue to expand indications
May 14, 2004Competitors in one of the industry's fastest growing markets, the TNF-blocker class of rheumatoid arthritis drugs, have gained extensions to …
New laws to combat animal rights extremists
May 14, 2004New legislation will be introduced to combat animal rights extremists' violence against those involved in using animals in medical research.But …
GSK sued for ‘abandoning’ Relenza
May 14, 2004Biota, the Australian biotech company that discovered Relenza, is taking GlaxoSmithKline to court, alleging that it failed to properly launch …
Antisoma and Roche’s ovarian cancer drug disappoints
May 12, 2004A phase III trial of a drug to treat ovarian cancer has disappointed and is likely to be dropped, co-developers …
Intervention from Paris secures French future for Aventis
May 7, 2004Aventis has dropped its long-running opposition to a takeover bid by French compatriots Sanofi-Synthlabo after the offer to its shareholders …
OTC Zocor to be cleared but divisions persist
April 28, 2004The government is shortly to announce the approval of the world's first over-the-counter statin, Zocor Heart Pro, but is unlikely …
Burson-Marsteller to launch cancer treatment in the UK
April 28, 2004Burson-Marsteller, a subsidiary of the WPP advertising giant, has been appointed PR campaign handler for the UK launch of Velcade, …
Patients still being denied access to colon cancer treatments
April 28, 2004A new Roche-sponsored survey of patients with bowel cancer has found that most are still not being consulted on the …
BMA chairman warns reforms add to threat of ‘two-tier NHS’
April 26, 2004The chairman of the BMA has warned that new reforms are adding to the threat of a two-tier NHS posed …
US legal action Aventis’ latest weapon in repelling Sanofi
April 26, 2004Aventis has unleashed its latest stratagem in resisting Sanofi-Synthleabo's hostile takeover bid, a US legal action claiming its rival has …
A tale of two pills for Pfizer in Q1
April 26, 2004Pfizer, torceptrapib
The first quarter of 2004 saw Pfizer’s biggest seller Lipitor extend its domination of the statin market but Viagra, another …
Latest content
FibroFind appoints Lee Borthwick as CEO
